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Cultured rat mesangial cells contain high affinity endothelin (ET) receptors at high densities. Exposure of these cells to ET resulted in a transient 
activation of topoisomerase I extractable activity, which reached its maximum value at approximately 2 min and returned to basal value after 
approximately 10 min of treatment. The activation of this enzyme was dependent upon the concentration of ET added. Incubation of the cells 
with pertussis toxin inhibited ET-induced increases in topoisomerase I activity in a concentration-dependent manner, suggesting the involvement 
of pertussis toxin-sensitive GTP-binding protein in ET-mediated action, Endothelin had no detectable ffect upon extractable topoisomerase II
activity. 
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1. INTRODUCTION 
Endothelin is a recently discovered 21 amino acid 
peptide with very potent vasoconstrictor properties [ 11. 
It is isolated from the supernatant of cultured porcine 
endothelial cells. The action of ET has been shown to be 
mediated through voltage-dependent calcium channels 
as well as through elevation of intracellular calcium. 
Endothelin receptors have been identified in several 
types of tissue such as kidney, brain, heart, and 
cultured cells of various tissue origins [2-51. Our 
laboratory has been interested in the signal transduction 
pathways mediated by ET receptors. We have used 
cultured rat renal mesangial cells as a model system to 
explore these pathways. The cells display high density, 
high affinity ET receptors that are coupled to the ac- 
tivation of phospholipase C and intracellular calcium 
release [6]. Activation of phospholipase C results in an 
increase in DAG levels and in the activation of protein 
kinase C which, in turn, leads to rapid expression of 
certain oncogenes such as c-myc and c-fos [7-91. We 
have also shown that exposure of vascular smooth mus- 
cle cells to vasopressin results in rapid induction of c-fos 
oncoprotein t101 and transiently increases 
topoisomerase I activity [ 111. 
Topoisomerase I (DNA topoisomerase; EC 5.99.1.2) 
and II are classes of enzymes which catalyze inter- 
conversions among topological isomers of DNA via 
transient single or double strand breaks [12,13]. They 
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are believed to regulate DNA metabolism, e.g. replica- 
tion and transcription [ 14-171. In the present study, we 
demonstrate that the interaction of ET with cultured 
mesangial cells results in an increase in topoisomerase I 
activity. 
2. MATERIALS AND METHODS 
Endothelin 1, 2 and 3 were from Peninsula Laboratories. Pertussis 
and cholera toxin were from List Biologicals (Campbell, CA). Col- 
lagenase was from Worthington Biochemical Corp. (Freehold, NJ). 
RPM1 1640 medium was from Gibco Labs (Grand Island, NY). In- 
sulin, penicillin and streptomycin were from Sigma Chemical Co. (St. 
Louis, MO). Fetal bovine serum was from Hazelton Labs (Logan, 
UT). All other chemicals were of the highest grade available. Human 
scleroderma ntiserum was kindly provided by Dr Gerd Maul of the 
Wistar Institute (Philadelphia, PA). 
2.1. Cell culture 
Mesangial cells were cultured from glomeruli obtained from the 
kidney cortices of 55-70 g rats (Sprague-Dawley, Charles River). 
Glomeruli were isolated by a sequential sieving which removes tubules 
(300 wrn, 150 pm), but retains glomeruli (63 hm). Isolated glomeruli 
were incubated for 10 min at 37°C in collagenase (750 pm/ml) and 
then plated in flasks in RPM 1640 medium supplemented with 0.6 
U/ml insulin, 100 U/ml penicillin, 100 pg/ml streptomycin, and 15% 
fetal bovine serum. Cells were grown at 37°C in 591a CO2, medium be- 
ing changed two times per week. At confluency, cells were sub- 
cultured after washing with Ca’+- and Mg2+ -free phosphate- 
buffered saline and incubated with trypsin supplemented with 20 mM 
EDTA. They were identified as mesangial cells by the following 
criteria: (i) a stellate morphology as determined by phase contrast 
microscopy; (ii) microfilaments and subplasmalemmal cytoplasmic 
densities as determined by transmission electron microscopy; (iii) in- 
sensitivity to puromycin aminonucleoside; and (iv) positive im- 
munofluorescence staining for actin and desmin but negative for 
keratin and factor VIII antigens. 
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Fig. 1. Mesangial cells were treated with 100 nM ET for the indicated 
times and topoisomerase I activity contained in nucleus extracts of the 
cells was determined as described in section 2. 
2.2. Preparation of nucleus extracts: assay for topoisomerase 
I activity 
Topoisomerase I activity contained in nucleus extracts was deter- 
mined according to Nambi et al. [f 11. Protein was determined by the 
method of Bradford f 181. 
2.3. Gel electrophoresis and immunobiotting 
SDS-polyacrylamide gels (1.5 mm thick; 4% stacking gel and 7% 
resolving gel) were electrophoresed on a Minigel apparatus (8 x 9 cm) 
at 20 mA. The proteins were transferred from the gel onto 
nitrocellulose (Schleicher and Schuel!, Keene, NH) by electroblotting 
in 5 mM 3-(cycfohexyIamino)-!-prop~esuIfonic acid, pH II, at 300 
mA overnight using a BioRad transfer apparatus. Blots were blocked 
with 1% BSA in TBST (20 mM Tris-HCl, pH 7.6, 137 mM NaCI, 
0.1 To Tween 20) and probed with human scleroderma ntiserum ap- 
propriately diluted into TEST. Blots were incubated with antibody 
for 2 h at room temperature. Following three 2-min washes in TBST, 
the blots were incubated with **‘I-Protein A (1 pCi/mI in TBST) for 
1 h at room temperature. The blots were then washed 3 times (2 min 
each wash) in TBST, air-dried, and autoradiographed with preflashed 
Kodak X-omat AR film. Autoradiograms were scanned with a 
Beckman DUdB spectrophotometer. Band intensities on the auto- 
radiograms were converted to relative amounts of topoisomerase 1. 
3. RESULTS 
Incubation of rat renal mesangial cells in culture with 
ET resulted in an increase in extractable topoisomerase 
I activity. This increase was transient, with m~imum 
activity observed in the first 5 min after hormone addi- 
tion (Fig. 1). Between 10 and 30 min after ET was added 
to the cultures, extractable topoisomerase I activity 
returned to basal level (Fig. 1). Under the same condi- 
tions, there was no detectable change in extractable 
topoisomerase II activity in response to ET (not 
shown). Immunoblot analysis demonstrated that 
neither the cellular content of topoisomerase I nor its 
extractability by 0.35 M NaCl was altered by 2 or 5 min 
incubation with 100 nM ET (Fig. 2); thus, the observed 
increase in topoisomerase I specific activity was likely 
TREATMENT 
TOPOISOMERASE I CONTENT* OF 
0.35&4 NaCl 
Extract 
Extracted 
Nuclei Total 
1.3 0.6 1.9 .68 
100 nM ET 
2 min 1.1 0.8 1.9 
5 min 1.1 0.6 1.7 
‘density units x 10 -7 
a b c d e f 
110 @ 
FRACTION OF 
TOPOISOMERASE I 
EXTRACTED 
58 
.65 
Fig. 2. Topoisomerase 1 content of 0.35 M NaCI nucleus extracts (a-c) and corresponding extracted nuclei (d-f) was assayed by immunoblotting 
with human scleroderma ntiserum. Equat amounts (IO pg) of protein were loaded onto each lane of the gel. (a,d) untreated; (b,e) 100 nM ET-I, 
2 min; (c,f) 100 nM ET-I, 5 min. 
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Fig. 3. Mesangial cells were incubated with increasing concentrations 
of ET for 2 mitt, and the topoisomerase I activity in the nucleus ex- 
tracts was assayed as described. Data are from one experiment 
representative of two. 
due to activation of enzyme that was present at the time 
of treatment. The increase in topoisomerase I activity 
also depended on the concentration of ET used (Fig. 3). 
The EC50 for ET was approximately 6.0 nM. Next, we 
tested the involvement of GTP binding protein in ET- 
mediated topoisomerase I activation. Cells were treated 
with increasing concentrations of pertussis toxin for 12 
h and then challenged with ET for 2 min. As shown in 
Fig. 4, increasing concentrations of pertussis toxin in- 
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Fig. 4. Mesangial cells were treated with various concentrations of 
pertussis toxin for 12 h and then challenged with 100 nM ET for 2 
min. Topoisomerase I activity in the nucleus extracts was assayed as 
described. Data are from one experiment representative of two. 
hibited ET-stimulated topoisomerase I activity, and at 1 
Fg.g/ml of pertussis toxin, the activation of 
topoisomerase I by ET was totally abolished. Pertussis 
toxin treatment did not affect basal topoisomerase I ac- 
tivity (not shown). 
4. DISCUSSION 
Activation of topoisomerases I and II have been 
demonstrated to be associated with induced gene activi- 
ty [ 15,161. By the use of a variety of agonist-responsive 
cells, it has been shown that binding of hormones to 
specific cell surface receptors activates phosphatidyl- 
inositol (PI) turnover, which results in the elevation of 
cytosolic calcium and diacylglycerol evels. The latter, 
in turn, activate protein kinase C [19,20]. These events 
induce rapid expression of certain oncogenes uch as c- 
myc and c-fos [7-lo]. It has been reported recently that 
the calcium ionophore, A23187, induces c-fos in A431 
cells and increases the frequency of camptothecin- 
induced topoisomerase I-linked DNA strand breakage 
in the induced gene [21]. Cellular content of c-fos 
mRNA and cellular topoisomerase I activity (camp- 
tothecin-induced breaks) were kinetically coupled, 
reaching maximum levels 10 min after induction before 
decreasing. We have previously demonstrated that ex- 
posure of vascular smooth muscle cells or human 
monocytic leukemia cells (U937) to hormones (vaso- 
pressin, thrombin) or cytokines (leukotrienes) results in 
the transient activation of nuclear topoisomerase I ac- 
tivity [11,22] as well as PKC [23]. Thus, release of in- 
tracellular Ca2 + and activation of protein kinase C by 
a number of hormone-dependent or -independent 
pathways appear to induce specific genes and con- 
comitantly activates topoisomerase I. 
Endothelin has been reported to stimulate the forma- 
tion of inositol phosphates and mobilization of calcium 
in a variety of cells, DNA synthesis in vascular smooth 
muscle cells, Swiss 3T3 cells, and c-fos in rat mesangial 
cells [24-271. In addition, inhibitors of PKC activation 
have been shown to obliterate the physiological effects 
of brief treatments with endothelin [28], suggesting that 
PKC stimulation is affected by ET. Here, we report that 
exposure of rat mesangial cells to ET likewise resulted 
in a transient stimulation of topoisomerase I activity. 
Since there was no change in either the cellular content 
or extractability of topoisomerase I when the cells were 
exposed to ET, the observed increase in topoisomerase 
I activity appears to be due to the activation of the en- 
zyme. This activation depended on the concentration of 
ET used and the time of exposure of the cells to the hor- 
mone. Subsequent to the spike of enhanced extractable 
topoisomerase I activity induced by ET was a decrease 
to sub-basal specific activity. Because this decline was 
observed in 2 of 2 experiments with ET and has been 
reported in experiments with vasopressin [I I], we 
believe that it is real. Prior treatment of the cells with 
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pertussis toxin completely abolished ET-mediated 
stimulation of topoisomerase I activity. Thus, ET, 
whose topoisomerase I effect is completely PT- 
sensitive, is distinguishable from hormones such as 
thrombin, whose effect is partially sensitive, or 
vasopressin, whose effect is insensitive to PT [l 11. It is 
of interest that in rat mesangial cells, ET-mediated 
Ca’ + mobilization has been determined to be PT- 
sensitive It;]_ Thus, the results reported here provide ad- 
ditional evidence for the interrelationships via specific 
G-protein coupling, of inositol-phosphate turnover, ac- 
tivation of nuclear enzymes such as topoisomerase I, 
and physiological effects of the hormone. 
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